| DC Field | Value | Language |
|---|
| dc.contributor.author | Gurova, N. A. | - |
| dc.contributor.author | Kosolapov, V. A. | - |
| dc.contributor.author | Smirnov, A. V. | - |
| dc.contributor.author | Babkov, D. A. | - |
| dc.contributor.author | Babkova, V. A. | - |
| dc.date.accessioned | 2026-10-12T13:56:34Z | - |
| dc.date.available | 2026-10-12T13:56:34Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | The effect of the azolo-triazine derivative AB-19 on the development of diabetic cardiomyopathy in rats / N.A. Gurova, V.A. Kosolapov, A.V. Smirnov [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №1.-P. 26-39. - DOI: 10.18413/rrpharmacology.12.1049. - Refer.: p. 37-38. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67104 | - |
| dc.description.abstract | This article presents data on the identification of functional and structural changes occurring during the development of diabetic cardiomyopathy and investigates the cardioprotective effects of the anti-glycating agents - the azolo-triazine derivative AB-19 and aminoguanidine | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | azolo-triazines | ru |
| dc.subject | antiglycation | ru |
| dc.subject | diabetic cardiomyopathy | ru |
| dc.subject | diabetes mellitus | ru |
| dc.title | The effect of the azolo-triazine derivative AB-19 on the development of diabetic cardiomyopathy in rats | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 1
|
